Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 22 Mar 21 424B4 Prospectus supplement with pricing info
- 18 Mar 21 EFFECT Notice of effectiveness
- 15 Mar 21 S-1/A IPO registration (amended)
-
10 Mar 21 S-1/A IPO registration (amended)
- 19 Feb 21 S-1 IPO registration
GANX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated February 19, 2021, in the Amendment No. 1 to the Registration Statement (Form S-1 No. 333-253303) and related Prospectus of Gain Therapeutics, Inc. for the registration of its common stock.
/s/ Ernst & Young AG
Lancy- Geneva, Switzerland
March 10, 2021